Overexpression of aldo-keto-reductase in azole-resistant clinical isolates of Candida glabrata determined by cDNA-AFLP

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Farahyar, Shirin ^a   Zaini, Farideh ^a   Kordbacheh, Parivash ^a   Rezaie, Sassan ^a   Safara, Mahin ^a   Raoofian, Reza ^c   Heidari, Mansour ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Aldo keto reductase; Azole; Candida glabrata; cDNA AFLP; Semi quantitative RT PCR

Indexed keywords

ALDO KETO REDUCTASE; COMPLEMENTARY DNA; FLUCONAZOLE; ITRACONAZOLE; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA GLABRATA; CANDIDIASIS; CONTROLLED STUDY; FUNGAL GENE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE OVEREXPRESSION; HUMAN; IMMUNOCOMPROMISED PATIENT; NONHUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84872368923     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-1     Document Type: Article

References (33)

1. Epidemiology of invasive candidiasis: a persistent public health problem. Pfaller M, Diekema D, Clin Microbiol Rev 2007 20 133 163 10.1128/CMR.00029-06 17223626 (Pubitemid 46167771)
2. Changing epidemiology of systemic fungal infections. Richardson M, Lass-Flörl C, Clin Microbiol Infect 2008 14 5 24 18430126 (Pubitemid 351593913)
3. Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts. Ruhnke M, Curr Drug Targets 2006 7 495 504 10.2174/138945006776359421 16611037 (Pubitemid 43744840)
4. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Fidel PL Jr, Vazquez JA, Sobel JD, Clin Microbiol Rev 1999 12 80 96 9880475 (Pubitemid 29055954)
5. Antifungal resistance in pathogenic fungi. Perea S, Patterson TF, Clin Infect Dis 2002 35 1073 1080 10.1086/344058 12384841 (Pubitemid 35239467)
6. An update on antifungal targets and mechanisms of resistance in Candida albicans. Akins RA, Med Mycol 2005 43 285 318 10.1080/13693780500138971 16110776 (Pubitemid 41030457)
7. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G, Antimicrob Agents Chemother 2005 49 668 679 10.1128/AAC.49.2.668-679.2005 15673750 (Pubitemid 40175679)
8. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Sanglard D, Ischer F, Bille J, Antimicrob Agents Chemother 2001 45 1174 1183 10.1128/AAC.45.4.1174-1183.2001 11257032 (Pubitemid 32230999)
9. The ATP binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1dependent azole resistance of Candida glabrata. Torelli R, Posteraro B, Ferrari S, La Sorda M, Fadda G, Sanglard D, Sanguinetti M, Mol Microbiol 2008 68 186 201 10.1111/j.1365-2958.2008.06143.x 18312269 (Pubitemid 351363785)
10. Molecular biological characterization of an azole-resistant Candida glabrata isolate. Marichal P, Vanden Bossche H, Odds FC, Nobels G, Warnock DW, Timmerman V, Van Broeckhoven C, Fay S, Mose-Larsen P, Antimicrob Agents Chemother 1997 41 2229 2237 9333053 (Pubitemid 27422218)
11. Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei. Lamping E, Ranchod A, Nakamura K, Tyndall JDA, Niimi K, Holmes AR, Niimi M, Cannon RD, Antimicrob Agents Chemother 2009 53 354 369 10.1128/AAC.01095-08 19015352
12. Upregulation of the ERG11 gene in Candida krusei by azoles. Tavakoli M, Zaini F, Kordbacheh M, Safara M, Raoofian R, Heidari M, DARU J Pharm Sci 2010 18 276 280
13. cDNA-AFLP analysis reveals differential gene expression in response to salt stress in foxtail millet (Setaria italica L.). Jayaraman A, Puranik S, Rai NK, Vidapu S, Sahu PP, Lata C, Prasad M, Mol Biotechnol 2008 40 241 251 10.1007/s12033-008-9081-4 18592419
14. Quantitative comparison of cDNA-AFLP, microarrays, and GeneChip expression data in Saccharomyces cerevisiae. Reijans M, Lascaris R, Groeneger AO, Wittenberg A, Wesselink E, van Oeveren J, Wit E, Boorsma A, Voetdijk B, van der Spek H, Genomics 2003 82 606 618 10.1016/S0888-7543(03)00179-4 14611802 (Pubitemid 37373717)
15. National Committe for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of yeasts Wayne, Pa: NCCLS NCCLS document M27-A2 National Committee for Clinical Laboratory Standards 2002. 2002
16. Interaction between ketoconazole, amphotericin B and terbinafin and three diazenumdiolates in concomitant uses against some fugal species. Falahati M, Shabani M, Rodaki MMA, Jahaniani F, Bagheri KP, Ebrahimi SA, DARU J Pharml Sci 2006 14 87 92 (Pubitemid 43971922)
17. Identification of novel p53 target genes by cDNA AFLP in glioblastoma cells. Saffari M, Dinehkabodi OS, Ghaffari SH, Modarressi MH, Mansouri F, Heidari M, Cancer Lett 2009 273 316 322 10.1016/j.canlet.2008.08.020 18814959
18. Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program. Pfaller MA, Diekema DJ, Gibbs DL, Newell VA, Barton R, Bijie H, Bille J, Chang SC, da Luz Martins M, Duse A, Diagn Microbiol Infect Dis 2010 67 162 171 10.1016/j.diagmicrobio.2010. 01.002 20338711
19. Mechanism of increased fluconazole resistance in Candida glabrata during prophylaxis. Bennett JE, Izumikawa K, Marr KA, Antimicrob Agents Chemother 2004 48 1773 1777 10.1128/AAC.48.5.1773-1777.2004 15105134 (Pubitemid 38544388)
20. Efflux pumps in drug resistance of Candida. Prasad R, Gaur N, Gaur M, Komath S, Infect Disord Drug Targets 2006 6 69 83 10.2174/187152606784112164 16789872 (Pubitemid 43881017)
21. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies. Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD, Mol Microbiol 2006 61 704 722 10.1111/j.1365-2958.2006.05235.x 16803598 (Pubitemid 44324094)
22. Mutations in the CgPDR1 and CgERG11 genes in azole-resistant Candida glabrata clinical isolates from Slovakia. Berila N, Borecka S, Dzugasova V, Bojnansky J, Subik J, Int J Antimicrob Agents 2009 33 574 578 10.1016/j.ijantimicag.2008.11.011 19196495
23. Molecular analysis of Candida glabrata clinical isolates. Berila N, Subik J, Mycopathologia 2010 170 99 105 10.1007/s11046-010-9298-1 20232155
24. Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence. Ferrari S, Ischer F, Calabrese D, Posteraro B, Sanguinetti M, Fadda G, Rohde B, Bauser C, Bader O, Sanglard D, PLoS Pathog 2009 5 1000268 10.1371/journal.ppat.1000268 19148266
25. Contribution of CgPDR1-regulated genes in enhanced virulence of azole-resistant Candida glabrata. Ferrari S, Sanguinetti M, Torelli R, Posteraro B, Sanglard D, PLoS One 2011 6 17589 10.1371/journal.pone.0017589 21408004
26. Comparison of gene expression profiles of Candida albicans azole-resistant clinical isolates and laboratory strains exposed to drugs inducing multidrug transporters. Karababa M, Coste AT, Rognon B, Bille J, Sanglard D, Antimicrob Agents Chemother 2004 48 3064 3079 10.1128/AAC.48.8.3064- 3079.2004 15273122 (Pubitemid 38989176)
27. The aldo-keto reductase superfamily and its role in drug metabolism and detoxification. Barski OA, Tipparaju SM, Bhatnagar A, Drug Metab Rev 2008 40 553 624 10.1080/03602530802431439 18949601
28. Aldo-keto reductase (AKR) superfamily: genomics and annotation. Mindnich RD, Penning TM, Hum Genomics 2009 3 362 370 19706366
29. Functional genomic studies of aldo-keto reductases. Petrash JM, Murthy B, Young M, Morris K, Rikimaru L, Griest TA, Harter T, Chem Biol Interact 2001 130 673 683 11306085 (Pubitemid 32295854)
30. Three genes whose expression is induced by stress in Saccharomyces cerevisiae. Garay-Arroyo A, Covarrubias AA, Yeast 1999 15 879 892 10.1002/(SICI)1097-0061(199907)15:10A<879::AID-YEA428>3.0.CO;2-Q 10407268
31. D-arabinose dehydrogenase and its gene from Saccharomyces cerevisiae. Kim ST, Huh WK, Lee BH, Kang SO, Biochim Biophys Acta 1998 1429 29 39 10.1016/S0167-4838(98)00217-9 9920381 (Pubitemid 29052206)
32. Functional studies of aldo-keto reductases in Saccharomyces cerevisiae. Chang Q, Griest TA, Harter TM, Mark Petrash J, Biochim Biophys Acta 2007 1773 321 329 10.1016/j.bbamcr.2006.10.009 17140678 (Pubitemid 46290669)
33. Disruption of aldo-keto reductase genes leads to elevated markers of oxidative stress and inositol auxotrophy in Saccharomyces cerevisiae. Chang Q, Petrash JM, Biochim Biophys Acta 2008 1783 237 245 10.1016/j.bbamcr.2007.08.008 17919749